Similarly, lncRNA metastasis-associated lung adenocarcinoma transcript1 (lncRNA-MALT1) has also been proposed as a potential biomarker for predicting the risk of acute exacerbation and disease progression in COPD [32]. This evidence concerns the gene MALT1 and chronic obstructive pulmonary disease.